You are here

eye health

Alcon Beats Expectations Since its Split from Novartis

Alcon Beats Expectations Since its Split from Novartis

Medical Devices and Diagnostics Industry

Flag link:

ReNeuron climbs on up dated vision loss cell therapy data

ReNeuron climbs on up dated vision loss cell therapy data

Fierce Biotech

Retinitis pigmentosa

Flag link:

Glaukos touts 5-year study of glaucoma stents

Glaukos touts 5-year study of glaucoma stents

Mass Device

Flag link:

Lukewarm data for Second Sight

Lukewarm data for Second Sight

EP Vantage

retinal prosthesis

Flag link:

Novartis completes spin-out of Alcon eye unit

Novartis completes spin-out of Alcon eye unit

Pharmaforum

Flag link:

Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases

Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases

Xconomy

Flag link:

Study Shows that Using AI in Eye Screenings Could Help Improve Vision Outcomes

Study Shows that Using AI in Eye Screenings Could Help Improve Vision Outcomes

Medical Devices and Diagnostics Industry

artificial intelligence

diabetic macular edema

Flag link:

New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug

New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug

Xconomy

Aldeyra Therapeutics

clinical trials

seasonal allergic conjunctivitis

Flag link:

Novartis says listing of Alcon eye care business expected on April 9

Novartis says listing of Alcon eye care business expected on April 9

Yahoo/Reuters

Flag link:

Ophthalmic Medtech Company Avedro Launches $92 Million IPO

Ophthalmic Medtech Company Avedro Launches $92 Million IPO

CP Wire

corneal ectatic disorders

Flag link:

Aurinia eye drug falls short in improving tolerability versus Restasis, but beats on efficacy

Aurinia eye drug falls short in improving tolerability versus Restasis, but beats on efficacy

Endpoints

Aurinia Pharmaceuticals

dry eye disease

Flag link:

Novartis unit Alcon picks up Tear Film Innovations

Novartis unit Alcon picks up Tear Film Innovations

Mass Device

Tear Film Innovations

Flag link:

Alcon's Acquisition Is a Real Tear-Jerker

Alcon's Acquisition Is a Real Tear-Jerker

Medical Devices and Diagnostics Industry

Flag link:

Novartis files for Alcon spinoff, citing aging population and developing countries as top growth prospects

Novartis files for Alcon spinoff, citing aging population and developing countries as top growth prospects

Fierce Pharma

Flag link:

New eye health companies gain funders’ focus

New eye health companies gain funders’ focus

Medical Design and Outsourcing

Flag link:

See, snap and fund: Johnson & Johnson Vision push for eye health to donate to charity for shared photos

See, snap and fund: Johnson & Johnson Vision push for eye health to donate to charity for shared photos

Fierce Pharma

Flag link:

Novartis says glaucoma stent setback will not derail Alcon spin-off

Novartis says glaucoma stent setback will not derail Alcon spin-off

Yahoo/Reuters

CyPass Micro-Stent

Flag link:

FDA approves Kala's twice-daily ocular steriod

FDA approves Kala's twice-daily ocular steriod

BioCentury

Kala Pharmaceuticals

ocular steriods

Flag link:

Novartis to spin out Alcon ophthalmic subsidiary

Novartis to spin out Alcon ophthalmic subsidiary

Mass Device

Flag link:

Report: Johnson & Johnson sees Vision Care biz grow, looks to expand beyond contacts

Report: Johnson & Johnson sees Vision Care biz grow, looks to expand beyond contacts

Mass Device

Flag link:

Pages